Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2016 08:00 ET | Source: Abiomed

Abiomed First Quarter Fiscal 2017 Earnings and Conference Call Notification

DANVERS, Mass., July 07, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, July 28, 2016, the Company will release financial results for the first quarter of fiscal...
June 07, 2016 08:00 ET | Source: ABIOMED, Inc.

Abiomed to Present at the William Blair 2016 Growth Stock Conference

DANVERS, Mass., June 07, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
June 03, 2016 09:00 ET | Source: ABIOMED, Inc.

Abiomed to Present at the Jefferies 2016 Healthcare Conference

DANVERS, Mass., June 03, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
May 03, 2016 07:00 ET | Source: ABIOMED, Inc.

Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year

DANVERS, Mass., May 03, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2016 revenue of...
April 12, 2016 08:00 ET | Source: ABIOMED, Inc.

Abiomed Fourth Quarter Fiscal 2016 Earnings and Conference Call Notification

DANVERS, Mass., April 12, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Tuesday, May 3, 2016, the Company will release financial results for the fourth quarter of fiscal...
April 12, 2016 08:00 ET | Source: ABIOMED, Inc.

Abiomed Impella Devices Support 37,673 Patients, Enough to Fill Historic Fenway Park

DANVERS, Mass., April 12, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, announced today that it has supported 37,673 patients...
April 08, 2016 18:56 ET | Source: ABIOMED, Inc.

アビオメッドのインペラ (Abiomed Impella®) 療法、心臓発作、心臓手術後の心原性ショックでFDAの承認を取得

米国マサチューセッツ州ダンヴァース発 , April 09, 2016 (GLOBE NEWSWIRE) -- 画期的な心臓サポートテクノロジーのリーダー的プロバイダーであるアビオメッド (Abiomed, Inc、NASDAQ:ABMD) は本日、インペラ2.5 (Impella 2.5™)、インペラCP (Impella CP®)、インペラ5.0 (Impella...
April 07, 2016 16:02 ET | Source: ABIOMED, Inc.

Abiomed Impella® Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery

DANVERS, Mass., April 07, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that it has received U.S. Food and Drug...
February 08, 2016 08:00 ET | Source: ABIOMED, Inc.

Abiomed Announces Appointments of Jeannine Rivet and Christopher Van Gorder to Board of Directors

DANVERS, Mass., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced the appointments of Jeannine Rivet and...
February 04, 2016 07:00 ET | Source: ABIOMED, Inc.

Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

U.S. Patient Utilization Grew 45%, Year Over Year Abiomed Increases Fiscal Year 2016 Revenue Guidance DANVERS, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading...